These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 24025401)

  • 1. Inhibition of hepatitis C virus infection by polyoxometalates.
    Qi Y; Xiang Y; Wang J; Qi Y; Li J; Niu J; Zhong J
    Antiviral Res; 2013 Nov; 100(2):392-8. PubMed ID: 24025401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific inhibition of hepatitis C virus entry into host hepatocytes by fungi-derived sulochrin and its derivatives.
    Nakajima S; Watashi K; Kamisuki S; Tsukuda S; Takemoto K; Matsuda M; Suzuki R; Aizaki H; Sugawara F; Wakita T
    Biochem Biophys Res Commun; 2013 Nov; 440(4):515-20. PubMed ID: 24099774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saikosaponin b2 is a naturally occurring terpenoid that efficiently inhibits hepatitis C virus entry.
    Lin LT; Chung CY; Hsu WC; Chang SP; Hung TC; Shields J; Russell RS; Lin CC; Li CF; Yen MH; Tyrrell DL; Lin CC; Richardson CD
    J Hepatol; 2015 Mar; 62(3):541-8. PubMed ID: 25450204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. (-)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus.
    Chen C; Qiu H; Gong J; Liu Q; Xiao H; Chen XW; Sun BL; Yang RG
    Arch Virol; 2012 Jul; 157(7):1301-12. PubMed ID: 22491814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Class of Small Molecule Compounds that Inhibit Hepatitis C Virus Infection by Targeting the Prohibitin-CRaf Pathway.
    Liu S; Wang W; Brown LE; Qiu C; Lajkiewicz N; Zhao T; Zhou J; Porco JA; Wang TT
    EBioMedicine; 2015 Nov; 2(11):1600-6. PubMed ID: 26870784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (-)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry.
    Calland N; Albecka A; Belouzard S; Wychowski C; Duverlie G; Descamps V; Hober D; Dubuisson J; Rouillé Y; Séron K
    Hepatology; 2012 Mar; 55(3):720-9. PubMed ID: 22105803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral activity of cuprous oxide nanoparticles against Hepatitis C Virus in vitro.
    Hang X; Peng H; Song H; Qi Z; Miao X; Xu W
    J Virol Methods; 2015 Sep; 222():150-7. PubMed ID: 26116793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activity-based and fraction-guided analysis of Phyllanthus urinaria identifies loliolide as a potent inhibitor of hepatitis C virus entry.
    Chung CY; Liu CH; Burnouf T; Wang GH; Chang SP; Jassey A; Tai CJ; Tai CJ; Huang CJ; Richardson CD; Yen MH; Lin CC; Lin LT
    Antiviral Res; 2016 Jun; 130():58-68. PubMed ID: 27012176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzhydrylpiperazine compounds inhibit cholesterol-dependent cellular entry of hepatitis C virus.
    Chamoun-Emanuelli AM; Pécheur EI; Chen Z
    Antiviral Res; 2014 Sep; 109():141-8. PubMed ID: 25019406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel small-molecule inhibitor of hepatitis C virus replication acts by suppressing signal transducer and activator of transcription 3.
    Niu Y; Si Y; Li Y; Chi X; Li X; Liu X; Li D; Cheng M; Fan J; Si S; Yang W
    J Antimicrob Chemother; 2015 Jul; 70(7):2013-23. PubMed ID: 25858355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Khaya grandifoliola C.DC: a potential source of active ingredients against hepatitis C virus in vitro.
    Galani BR; Sahuc ME; Sass G; Njayou FN; Loscher C; Mkounga P; Deloison G; Brodin P; Rouillé Y; Tiegs G; Séron K; Moundipa PF
    Arch Virol; 2016 May; 161(5):1169-81. PubMed ID: 26843184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of peptides binding to HCV e2 and inhibiting viral infectivity.
    Hong HW; Lee SW; Myung H
    J Microbiol Biotechnol; 2010 Dec; 20(12):1769-71. PubMed ID: 21193836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of hepatitis C virus by the flavonoid quercetin is mediated by inhibition of NS3 protease activity.
    Bachmetov L; Gal-Tanamy M; Shapira A; Vorobeychik M; Giterman-Galam T; Sathiyamoorthy P; Golan-Goldhirsh A; Benhar I; Tur-Kaspa R; Zemel R
    J Viral Hepat; 2012 Feb; 19(2):e81-8. PubMed ID: 22239530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves.
    Wahyuni TS; Widyawaruyanti A; Lusida MI; Fuad A; Soetjipto ; Fuchino H; Kawahara N; Hayashi Y; Aoki C; Hotta H
    Fitoterapia; 2014 Dec; 99():276-83. PubMed ID: 25454460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dioscin's antiviral effect in vitro.
    Liu C; Wang Y; Wu C; Pei R; Song J; Chen S; Chen X
    Virus Res; 2013 Mar; 172(1-2):9-14. PubMed ID: 23238077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.
    Cheng YL; Lan KH; Lee WP; Tseng SH; Hung LR; Lin HC; Lee FY; Lee SD; Lan KH
    Clin Sci (Lond); 2013 Nov; 125(9):439-48. PubMed ID: 23659500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a series of 1,3,4-trisubstituted pyrazoles as novel hepatitis C virus entry inhibitors.
    Hwang JY; Kim HY; Park DS; Choi J; Baek SM; Kim K; Kim S; Seong S; Choi I; Lee HG; Windisch MP; Lee J
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6467-73. PubMed ID: 24125883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The science of direct-acting antiviral and host-targeted agent therapy.
    Pawlotsky JM
    Antivir Ther; 2012; 17(6 Pt B):1109-17. PubMed ID: 23188746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.